Lysogene: LYSOGENE : Inside Information / News release on accounts, results

(marketscreener.com) PRESS RELEASE Lysogene Announces Postponement of 2022 Financial Results Release Paris, France - 29 April 2023 at 06:00 pm CET - Lysogene , a phase 3 gene therapy platform Company targeting central nervous system diseases, announces that it will not be able to...https://www.marketscreener.com/quote/stock/LYSOGENE-33951021/news/LYSOGENE-Inside-Information-News-release-on-accounts-results-43690554/?utm_medium=RSS&utm_content=20230429